Joanna Perry‐Keene

Queensland Health

Papers

3

Total Citations

725

H-Index

3

About

Joanna Perry‐Keene is a leading urological surgeon and researcher whose work has fundamentally shaped the modern surgical management of prostate cancer. Her primary research focus lies in the rigorous, evidence-based comparison of robotic-assisted laparoscopic prostatectomy (RALP) versus traditional open radical retropubic prostatectomy. Her landmark contribution is the first randomised controlled phase 3 study comparing these techniques, published in *The Lancet* (2016), which has garnered over 690 citations. This pivotal trial provided early, high-quality data on functional and oncological outcomes, directly informing clinical decision-making worldwide. Beyond her work on prostate cancer, Perry‐Keene has made notable contributions to rare urological pathology, including a seminal case review on primary vesical clear cell adenocarcinoma arising from endometriosis, a condition with sparse literature. Her dedication to prospective randomised trials in surgical oncology—evidenced by her ongoing work from 2013—demonstrates a commitment to moving beyond anecdotal evidence. Through her research, Perry‐Keene has helped establish the evidence base for robotic surgery, influencing surgical practice and improving patient outcomes across the globe.

Research Focus

Key Achievements

3
H-Index
3
Papers
725
Total Citations
242
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study
692 citations · 2016
📈 Most Prolific Year: 2013 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Queensland Health

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago